Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection
暂无分享,去创建一个
Todd M. Allen | B. Walker | M. Addo | R. Draenert | C. Verrill | N. Brown | A. Wurcel | Y. Tang | T. Suscovich | A. Kim | R. Draenert | C. L. Verrill | Y. Tang | T. M. Allen | A. G. Wurcel | M. Boczanowski | A. Lechner | A. Y. Kim | T. Suscovich | N. V. Brown | M. M. Addo | B. D. Walker | M. Boczanowski | A. Lechner | A. Wurcel
[1] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[2] B. Walker,et al. Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study. , 2003, The Journal of infectious diseases.
[3] Jay A. Berzofsky,et al. High-Avidity CTL Exploit Two Complementary Mechanisms to Provide Better Protection Against Viral Infection Than Low-Avidity CTL , 2001, The Journal of Immunology.
[4] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[5] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[6] V. Jansen,et al. The Role of T Cell Help for Anti-viral Ctl Responses , 2001 .
[7] A. Meyerhans,et al. In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity , 1991, European journal of immunology.
[8] D. Strick,et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.
[9] H. Günthard,et al. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Watkins,et al. Differences Between T Cell Epitopes Recognized After Immunization and After Infection1 , 2002, The Journal of Immunology.
[11] D. Montefiori,et al. Effect of Humoral Immune Responses on Controlling Viremia during Primary Infection of Rhesus Monkeys with Simian Immunodeficiency Virus , 2003, Journal of Virology.
[12] Todd M. Allen,et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection , 2003, AIDS (London).
[13] J. Guillet,et al. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses. , 2001, Virology.
[14] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[15] E. Rosenberg,et al. Vpr Is Preferentially Targeted by CTL During HIV-1 Infection1 , 2001, The Journal of Immunology.
[16] D. Watkins,et al. Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 , 2002, Journal of Virology.
[17] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[18] F. Lemonnier,et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.
[19] W. Blattner,et al. Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences , 1999, Journal of Virology.
[20] S. Kostense,et al. Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection , 2002, AIDS.
[21] R. Koup,et al. Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production. , 2001, Immunology letters.
[22] E. Rosenberg,et al. Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay , 2000, Journal of Virology.
[23] E. Wherry,et al. Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.
[24] Edward C. Holmes,et al. Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.
[25] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[26] M. Altfeld,et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. , 2003, Journal of immunological methods.
[27] S. Rowland-Jones,et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.
[28] E. Rosenberg,et al. Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection , 2001, The Journal of experimental medicine.
[29] B. Walker,et al. Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection , 1999, Journal of Virology.
[30] M. Mulligan,et al. Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.
[31] Austin L. Hughes,et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection , 2002, Nature Medicine.
[32] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[33] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[34] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[35] B. Walker,et al. T lymphocyte responses in HIV-1 infection: implications for vaccine development. , 1999, Current opinion in immunology.
[36] F. Miedema,et al. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. , 1997, The Journal of general virology.
[37] J. Lieberman,et al. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. , 2000, Blood.
[38] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[39] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[40] R. Phillips,et al. Immunology taught by Darwin , 2002, Nature Immunology.
[41] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Hallahan,et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.
[43] R. Schooley,et al. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. , 2001, The Journal of infectious diseases.
[44] C. Hallahan,et al. The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors To Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences , 2003, Journal of Virology.
[45] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[46] B. Walker,et al. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. , 1999, Journal of immunology.
[47] Alessandro Sette,et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.
[48] J. Lieberman,et al. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. , 2003, Blood.
[49] K. Harada,et al. Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.
[50] Lawrence Corey,et al. Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection , 2003, Journal of Virology.
[51] B. Walker,et al. HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other , 2000, Journal of Virology.
[52] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[53] Todd M. Allen,et al. Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences , 2003, Journal of Virology.
[54] E. Rosenberg,et al. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.
[55] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[56] B. Walker,et al. Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes , 2003, The Journal of experimental medicine.
[57] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[58] J. Berzofsky,et al. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.